Barriers to HIV pre-exposure prophylaxis among African, Caribbean and Black men in Toronto, Canada

PLoS One. 2019 Mar 29;14(3):e0213740. doi: 10.1371/journal.pone.0213740. eCollection 2019.

Abstract

Introduction: Single-tablet combination emtricitabine/tenofovir is highly effective as HIV pre-exposure prophylaxis (PrEP). Scale-up efforts have targeted men who have sex with men (MSM), but patterns of racial disparities in PrEP use have begun to emerge. African, Caribbean and Black (ACB) communities in Canada and USA are also disproportionately affected by HIV, and there is lack of guidance regarding PrEP implementation in this priority population.

Methods: ACB men from Toronto, Canada were recruited in community settings by peers. Participants completed a detailed socio-behavioural questionnaire. Biological samples were collected and tested for sexually transmitted infections. Willingness to accept PrEP was assessed in relation to actual and self-perceived risk of acquiring HIV, as well as demographic and behavioural variables.

Results: 424 ACB men were included in the analysis. ACB MSM were more likely to accept PrEP than ACB men only reporting sex with women (MSW; 50.0% vs. 23.6%). The most common reasons for PrEP non-acceptance were concerns regarding side-effects and low self-perceived risk. PrEP acceptance was lowest among younger men (12.5%) and those born in Canada (15.2%). Men with a high self-perceived HIV risk were more likely to accept PrEP (41.3% vs. 22.7% of men with a low self-perceived risk), but only 25.4% of men who were defined as being at high-risk, self-identified themselves as such.

Conclusions: Most ACB MSW were unlikely to accept PrEP, largely due to low self-perceived HIV risk, but PrEP acceptance among ACB MSM was similar to other contemporaneous Toronto MSM communities. PrEP acceptance was particularly low among younger ACB men and those born in Canada. Tailored strategies will be needed to effectively implement PrEP in Toronto ACB communities.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Age Factors
  • Anti-HIV Agents / therapeutic use
  • Black or African American / statistics & numerical data
  • Canada
  • Emtricitabine / therapeutic use
  • HIV Infections / ethnology
  • HIV Infections / prevention & control
  • HIV Infections / psychology*
  • Health Knowledge, Attitudes, Practice
  • Hispanic or Latino / statistics & numerical data
  • Homosexuality, Male / psychology
  • Humans
  • Logistic Models
  • Male
  • Middle Aged
  • Pre-Exposure Prophylaxis / statistics & numerical data*
  • Risk
  • Surveys and Questionnaires
  • Tenofovir / therapeutic use
  • Young Adult

Substances

  • Anti-HIV Agents
  • Tenofovir
  • Emtricitabine